T W P Friedl
Overview
Explore the profile of T W P Friedl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hauner D, Gunther J, Schederecker F, Donik L, Meyer D, Hermsdorfer J, et al.
Clin Nutr
. 2024 Nov;
43(12):243-244.
PMID: 39520784
No abstract available.
2.
Muller V, Banys-Paluchowski M, Friedl T, Fasching P, Schneeweiss A, Hartkopf A, et al.
ESMO Open
. 2021 Nov;
6(6):100299.
PMID: 34839105
Background: Circulating tumor cells (CTCs) have been reported to predict clinical outcome in metastatic breast cancer (MBC). Biology of CTCs may differ from that of the primary tumor and HER2-positive...
3.
Widschwendter P, Janni W, Scholz C, De Gregorio A, de Gregorio N, Friedl T
Arch Gynecol Obstet
. 2019 Nov;
300(6):1709-1718.
PMID: 31696367
Purpose: Lymph node metastases significantly worsen the prognosis in cervical carcinoma. Risk factors-pathological and patient related-could select patients at high risk for lymph node involvement. Methods: This retrospective analysis was...
4.
de Gregorio N, De Gregorio A, Ebner F, Friedl T, Huober J, Hefty R, et al.
Arch Gynecol Obstet
. 2019 Apr;
300(1):161-168.
PMID: 31011878
Background: Pelvic exenterations are a last resort procedure for advanced gynecologic malignancies with elevated risks in terms of patients' morbidity. Methods: This single-center analysis reports surgical details, outcome and survival...
5.
Lato K, Bekes I, Widschwendter P, Friedl T, Janni W, Reister F, et al.
Arch Gynecol Obstet
. 2018 Jan;
297(3):667-674.
PMID: 29330635
Purpose: Hypotension due to spinal anesthesia is a well-known side effect in pregnant women receiving caesarean section. Little is known about its impact on fetal blood circulation. Methods: 40 women...
6.
Jaeger B, Neugebauer J, Andergassen U, Melcher C, Schochter F, Mouarrawy D, et al.
PLoS One
. 2017 Jun;
12(6):e0173593.
PMID: 28586395
Background: HER2 is one of the predominant therapeutic targets in breast cancer. The metastatic selection process may lead to discrepancies between the HER2 status of the primary tumor and circulating...
7.
Schroder L, Rack B, Sommer H, Koch J, Weissenbacher T, Janni W, et al.
Geburtshilfe Frauenheilkd
. 2016 May;
76(5):542-550.
PMID: 27239063
This paper aims to evaluate the toxicity profile of additive gemcitabine to adjuvant taxane-based chemotherapy in breast cancer patients. Patients enrolled in this open-label randomized controlled Phase III study were...
8.
Janni W, Harbeck N, Rack B, Augustin D, Jueckstock J, Wischnik A, et al.
Br J Cancer
. 2016 Apr;
114(8):863-71.
PMID: 27031854
Background: Taxane-containing adjuvant chemotherapy has been established as standard treatment in node-positive breast cancer. This study compared efficacy and tolerability of epirubicin (E)/cyclophosphamide (C) followed by docetaxel (Doc) with a...
9.
Obermeier K, Sachsenweger J, Friedl T, Pospiech H, Winqvist R, Wiesmuller L
Oncogene
. 2015 Dec;
35(29):3796-806.
PMID: 26640152
Hereditary heterozygous mutations in a variety of DNA double-strand break (DSB) repair genes have been associated with increased breast cancer risk. In the Finnish population, PALB2 (partner and localizer of...
10.
Jaeger B, Jueckstock J, Andergassen U, Salmen J, Schochter F, Fink V, et al.
Biomed Res Int
. 2014 May;
2014:491459.
PMID: 24800234
Background: Evidence is accumulating that circulating tumor cells (CTC) out of peripheral blood can serve as prognostic marker not only in metastatic but also in early breast cancer (BC). Various...